42 Stocks Moving In Monday's Mid-Day Session

Gainers

• Obseva SA (NASDAQ:OBSV) climbed 34 percent to $19.50 The clinical-stage biopharma company that focuses on addressing conditions related to reproductive health and pregnancy said its phase 2b clinical trial of its linzagolix therapy achieved primary and secondary endpoints.
• Gevo, Inc. (NASDAQ:GEVO) shares jumped 31.7 percent to $4.624 after the company disclosed that the EPA has approved registration of isobutanol in 16% blends in gasoline.
• PTC Therapeutics, Inc. (NASDAQ:PTCT) shares jumped 27.5 percent to $47.88 in pre-market trading. The biopharmal company that develops treatments for rare disorders announced updated interim clinical data from a clinical study of its risdiplam therapy in babies with Type 1 Spinal Muscular Atrophy. William Blair upgraded PTC Therapeutics from Market Perform to Outperform.
• Xspand Products Lab, Inc. (NASDAQ:XSPL) surged 26.1 percent to $9.5298. Xspand Products Lab reported development of a new line of interactive light-up consumer products.
• China Biologic Products Holdings, Inc. (NASDAQ:CBPO) shares surged 23.9 percent to $101.64 following 13D filing indicating non-binding offer for $110 per share.
• Rent-A-Center Inc (NASDAQ:RCII) gained 22.4 percent to $14.73 on news that the board unanimously approved a sale to Vintage Capital for about $1.365 billion including debt.
• Verastem, Inc. (NASDAQ:VSTM) rose 18.9 percent to $7.761 after the company’s duvelisib showed robust clinical activity in CLL.
• Energy XXI Gulf Coast, Inc. (NASDAQ:EGC) jumped 18.7 percent to $8.89 after acquisition by Cox Oil for $9.10 per share in cash.
• Surface Oncology, Inc. (NASDAQ:SURF) rose 17 percent to $16.94.
• Francesca's Holdings Corporation (NASDAQ:FRAN) gained 14.9 percent to $7.02. B. Riley FBR upgraded Francesca's from Neutral to Buy.
• Nano Dimension Ltd. (NASDAQ:NNDM) rose 14.6 percent to $2.67.
• Monaker Group, Inc. (NASDAQ:MKGI) climbed 14.3 percent to $3.20.
• Puxin Limited (NYSE:NEW) rose 14.2 percent to $23.99 after climbing 23.53 percent on Friday.
• Cocrystal Pharma, Inc. (NASDAQ:COCP) gained 14.1 percent to $3.80.
• Quotient Limited (NASDAQ:QTNT) climbed 13.7 percent to $8.1175 in pre-market trading. Quotient reported concordance data from the MosaiQ European field trial.
• Stein Mart, Inc. (NASDAQ:SMRT) shares rose 12.7 percent to $2.85
• Hebron Technology Co., Ltd. (NASDAQ:HEBT) gained 11.9 percent to $2.305.
• Teekay Tankers Ltd. (NYSE:TNK) rose 10.9 percent to $1.12. Teekay Tankers Shareholders expanded the number of authorized shares from 285,000 to 485,000. Wells Fargo upgraded Teekay from Market Perform to Outperform.
• Penn Virginia Corporation (NASDAQ:PVAC) rose 9 percent to $83.97. Penn Virginia will replace Analogic in the S&P SmallCap 600 on Friday, June 22.
• Vince Holding Corp. (NYSE:VNCE) gained 8.2 percent to $16.12.
• TapImmune, Inc. (NASDAQ:TPIV) rose 8.1 percent to $11.35.
• Navios Maritime Partners L.P. (NYSE:NMM) shares rose 7.3 percent to $1.91. Navios Maritime reported the sale of one containership and options to sell four additional containerships.
• Frontline Ltd. (NYSE:FRO) shares rose 6.4 percent to $5.83. Wells Fargo upgraded Frontline from Market Perform to Outperform.
• Solid Biosciences Inc (NASDAQ:SLDB) gained 6 percent to $28.09 in reaction to a favorable development with the FDA. The company that focuses on treatments for Duchenne muscular dystrophy said the FDA removed a clinical hold on its investigational therapy SGT-001 after addressing the agency's questions.
• Evofem Biosciences, Inc. (NASDAQ:EVFM) rose 5.8 percent to $3.47. Oppenheimer initiated coverage on Evofem Biosciences with an Outperform rating.
• Quad/Graphics, Inc. (NYSE:QUAD) gained 5.8 percent to $21.64. Buckingham initiated coverage on Quad/Graphics with a Buy rating.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Catalyst Biosciences, Inc. (NASDAQ:CBIO) dipped 56.7 percent to $10.93 after the company issued an update on CB 2679d/ISU304 Factor IX clinical program in hemophilia B.
• Ambow Education Holding Ltd. (NYSE:AMBO) fell 21 percent to $5.81 after climbing 79.27 percent on Friday.
• Apollo Medical Holdings, Inc. (NASDAQ:AMEH) shares declined 19.3 percent to $20.87 after surging 59.53 percent on Friday.
• NF Energy Saving Corporation (NASDAQ:NFEC) shares fell 18.9 percent to $3.05.
• Hexindai Inc. (NASDAQ:HX) shares declined 18.9 percent to $9.46.
• Cytokinetics, Incorporated (NASDAQ:CYTK) declined 16.2 percent to $8.30 after the company reported that data from Phase 2 clinical study of reldesemtiv in patients with spinal muscular atrophy were presented at the 2018 Annual Cure SMA Conference.
• InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) slipped 15.8 percent to $4.885
• ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) dropped 13.7 percent to $3.71 after the company disclosed that the FDA has placed a clinical hold on a Phase 1 trial to evaluate CD19-specific CAR-T therapies.
• Baytex Energy Corp. (NYSE:BTE) shares tumbled 12.2 percent to $3.3900 as the company announced plans to buy Raging River.
• Melinta Therapeutics, Inc. (NASDAQ:MLNT) dropped 10.3 percent to $8.117.
• MarineMax, Inc. (NYSE:HZO) fell 9.6 percent to $21.65. B. Riley FBR downgraded MarineMax from Buy to Neutral.
• Grupo Supervielle S.A. (NYSE:SUPV) shares dropped 9.1 percent to $13.23.
• iPic Entertainment Inc. (NASDAQ:IPIC) shares fell 8.4 percent to $8.935
• Superior Drilling Products, Inc. (NYSE:SDPI) shares declined 8 percent to $1.89.
• BBVA Banco Francés S.A. (NYSE:BFR) fell 7.1 percent to $13.67.
• Intel Corporation (NASDAQ:INTC) dropped 4.2 percent to $52.83. Northland Securities downgraded Intel from Market Perform to Underperform.